芒果藤黄
传统医学
啮齿动物模型
啮齿动物
荟萃分析
糖尿病
医学
生物
内科学
内分泌学
生态学
作者
Moragot Chatatikun,Aman Tedasen,Phichayut Phinyo,Pakpoom Wongyikul,Wiyada Kwanhian Klangbud,Fumitaka Kawakami,Motoki Imai,Sirithip Chuaijit,Sarawut Rachmuangfang,Siriporn Phuwarinyodsakul,Rattana Leelawattana,Atthaphong Phongphithakchai
标识
DOI:10.3389/fphar.2024.1472419
摘要
Background Diabetes mellitus is a significant global health issue, and alternative treatments from natural products like Garcinia mangostana L. [Clusiaceae] or GM are being explored for their potential benefits. This study focused on evaluating the hypoglycemic effects of GM on diabetic rodent models. Methods A comprehensive search was conducted in PubMed, Scopus, and Embase for studies reporting blood glucose levels within 2 weeks as the primary outcome and changes in total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) as secondary outcomes. A network meta-analysis (NMA) was performed to determine the pooled effectiveness of each intervention, estimating the weighted mean difference (WMD) and 95% confidence interval (CI) from both direct and indirect evidence. The surface under the cumulative ranking curve (SURCA) was used to rank the interventions. Results Ten articles were identified, with nine included for quantitative analysis. All GM extracts showed greater effectiveness than the control in decreasing blood glucose levels within 2 weeks. GM at 200 mg/kg (GM200) was the top-ranked extract for reducing glucose levels beyond 2 weeks and increasing HDL-C levels. The ethanol extract of GM at 200 mg/kg (GME200) was the most effective for blood glucose reduction within 2 weeks and for TC and TG reductions. The methanol extract of GM at 200 mg/kg (GMM200) was the top-ranked extract for LDL-C reductions. Conclusion GM and its extracts demonstrated significant hypoglycemic activity and improvements in lipid profiles in diabetic rodent models, highlighting their potential as therapeutic agents for the prevention and treatment of diabetes mellitus. Further research in human trials is warranted to confirm these findings and establish clinical applications. Clinical trial registration https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023426254 .
科研通智能强力驱动
Strongly Powered by AbleSci AI